Neuronetics Stock Rises 1.85% Following Q2 Revenue Beat

Key Facts

1Neuronetics reported Q2 revenue of $41.57 million, surpassing analyst estimates by 3.20%.

2The company narrowed its adjusted loss to $0.05 per share during the period.

Neuronetics reported Q2 revenue of $41.57 million for the period ended June 2026, surpassing analyst estimates by 3.20%. According to AD HOC NEWS, the company narrowed its adjusted loss to $0.05 per share during the period, performing better than the consensus estimate of a $0.11 loss.

STIM closed at $2.20 on October 5, 2026, with the stock reaching a day high of $2.28 and a low of $2.13. The company's market capitalization stood at $153.1 million on the same date, while Ground News reported that BTIG reaffirmed a "Buy" rating on the stock with a price target of $6.00.